Pharmacovigilance: Adverse Drug Reactions in Antihypertensive and Antidiabetic Medications
a statistical study of adverse drug reactions of antihypertensive and antidiabetic drugs in gadhinglaj rural region
Journal name: World Journal of Pharmaceutical Research
Original article title: Pharmacovigilance
The WJPR includes peer-reviewed publications such as scientific research papers, reports, review articles, company news, thesis reports and case studies in areas of Biology, Pharmaceutical industries and Chemical technology while incorporating ancient fields of knowledge such combining Ayurveda with scientific data.
This page presents a generated summary with additional references; See source (below) for actual content.
Subtitle: a dire need in unani system of medicine
Original source:
This page is merely a summary which is automatically generated hence you should visit the source to read the original article which includes the author, publication date, notes and references.
M. Nafees Khan, Mumtaz Ahmad, Jamal Akhtar and M. A. Khan
World Journal of Pharmaceutical Research:
(An ISO 9001:2015 Certified International Journal)
Full text available for: Pharmacovigilance
Source type: An International Peer Reviewed Journal for Pharmaceutical and Medical and Scientific Research
Doi: 10.20959/wjpr201819-13703
Copyright (license): WJPR: All rights reserved
Summary of article contents:
Introduction
The study conducted by Tandale et al. explores the significant issue of adverse drug reactions (ADRs) related to antihypertensive and antidiabetic medications in the Gadhinglaj rural region. ADRs pose severe health risks that can complicate treatment regimens, potentially leading to therapy discontinuation. The research aims to identify common ADRs for these medications, with a primary focus on understanding the implications for patient care and safety. By gathering data from healthcare professionals in local hospitals, the authors intend to address the need for improved drug safety measures and patient counseling in managing hypertension and diabetes.
Antihypertensive Medications and ADRs
Among the antihypertensive drugs studied, Amlodipine, a calcium channel blocker, stood out for exhibiting the highest incidence of adverse drug reactions. In the survey, 11 out of 105 Amlodipine users reported ADRs, reflecting a notable rate of 10.5%. Other drugs such as Nifedipine, Atenolol, and Metoprolol also demonstrated various ADRs, with bradycardia being one of the most commonly reported reactions. This variation highlights the need for healthcare professionals to be vigilant regarding potential side effects associated with different antihypertensive therapies, ensuring patients are adequately monitored and counseled.
Antidiabetic Medications and ADRs
The research also focused on the ADRs associated with antidiabetic drugs, where Metformin emerged as the leading medication with a significant number of reported adverse reactions, specifically nine cases out of 150 patients. The study found that Glimepride and Voglibose were commonly used but exhibited fewer adverse reactions compared to Metformin. The findings underscore the complexities of managing diabetes pharmacotherapy, as healthcare providers must balance efficacy with the potential for unwanted side effects. These results emphasize the need for personalized treatment strategies to mitigate risks associated with antidiabetic medications.
Statistical Analysis of ADRs
To evaluate the data systematically, the authors employed the Kruskal-Wallis Test, a non-parametric statistical method, to determine the relationship between ADRs of antihypertensive and antidiabetic medications. The analysis concluded that there is no significant correlation between the ADRs of these drug classes, rejecting the null hypothesis. This finding indicates that while both types of medications may induce distinct reactions, the occurrence of ADRs does not explicitly relate between the two classes. As a result, this suggests that each class of medication may require targeted monitoring and intervention strategies specific to the risks they pose.
Conclusion
The study emphasizes the critical importance of pharmacovigilance in managing antihypertensive and antidiabetic therapies. As both conditions are prevalent in the population, healthcare providers are tasked with ensuring that patients receive optimal care with minimal risk of adverse reactions. The findings call attention to the necessity for robust patient education and counseling regarding medication use and side effects. Furthermore, while the lack of correlation between ADRs of antihypertensive and antidiabetic medications was observed, the outcomes of this research could pave the way for further studies focused on enhancing drug safety protocols and patient health outcomes in rural healthcare settings.
FAQ section (important questions/answers):
What is the main objective of the pharmacovigilance study?
The study aims to investigate adverse drug reactions (ADRs) associated with antihypertensive and antidiabetic medications, identify drugs with fewer ADRs, and encourage safe drug usage.
How was data collected for this study on ADRs?
Data was collected through surveys conducted in hospitals treating hypertensive and diabetic patients. Interactions with doctors provided information on the ADRs experienced by patients on specific medications.
Which antihypertensive drug showed the highest number of ADRs?
Amlodipine, a calcium channel blocker, displayed the highest number of ADRs compared to other antihypertensive medications in the study.
What were the most common ADRs experienced by patients?
Patients commonly experienced ADRs such as bradycardia among antihypertensive drugs and edema with antidiabetic medications, particularly with metformin.
What statistical method was used to analyze ADR data?
The Kruskal-Wallis test, a non-parametric statistical method, was employed to analyze the ADR data and test the relationship between antihypertensive and antidiabetic drug reactions.
What conclusion was drawn regarding the relationship between ADRs?
The study concluded that there is no significant relationship between adverse drug reactions of antihypertensive and antidiabetic drugs, as established by the Kruskal-Wallis test results.
Glossary definitions and references:
Scientific and Ayurvedic Glossary list for “Pharmacovigilance: Adverse Drug Reactions in Antihypertensive and Antidiabetic Medications”. This list explains important keywords that occur in this article and links it to the glossary for a better understanding of that concept in the context of Ayurveda and other topics.
1) Drug:
Drugs are multiple substances utilized for treatment, prevention, or diagnosis of diseases. Studying drugs involves examining their efficacy, safety, and any potential adverse effects they may cause, as highlighted in the survey of antihypertensive and antidiabetic drugs.
2) Study (Studying):
Study signifies the systematic investigation aimed at understanding specific phenomena. In this context, it pertains to the analysis of adverse drug reactions associated with antihypertensive and antidiabetic medications, focusing on data collection and statistical analysis.
3) Disease:
Diseases are conditions that disrupt normal bodily functions, commonly leading to health complications. The study focuses on prevalent conditions such as hypertension and diabetes, emphasizing understanding their treatment through pharmacovigilance.
4) Blood:
Blood is a vital fluid in the body responsible for transporting essential substances such as oxygen and nutrients to cells while removing waste products. Monitoring blood pressure is essential for diagnosing and managing diseases like hypertension.
5) Edema (Oedema):
Edema is the swelling caused by excess fluid accumulation in tissues. It can be a side effect of certain medications, particularly in treating conditions like hypertension and diabetes, necessitating effective monitoring and management.
6) Medicine:
Medicine refers to the science and practice of diagnosing, treating, and preventing disease. Medications are integral to treating conditions like diabetes and hypertension, but their side effects must be carefully monitored to ensure patient safety.
7) Table:
Table signifies a structured arrangement used to organize and present data systematically. In research, tables are fundamental for displaying results, such as the frequency of adverse drug reactions in the study of drugs related to hypertension and diabetes.
8) Pharmacological:
Pharmacological relates to the branch of medicine that deals with the study of drugs and their effects on living systems. It encompasses various aspects, including drug effects, mechanisms, and the therapeutic roles of medications in managing diseases.
9) Channel:
Channel specifically refers to calcium channel blockers that are pharmacological agents used to manage hypertension. Understanding the role of channel blockers in causing adverse drug reactions is essential for developing safer medications.
10) Science (Scientific):
Science encompasses systematic frameworks and methodologies for investigating phenomena, including drug development and pharmacovigilance. It allows researchers to analyze adverse drug reactions, significantly improving patient safety and treatment efficacy.
11) Diet:
Diet refers to the food and drink a person consumes, which can significantly influence health and the progression of diseases like diabetes. Dietary changes are essential for managing such chronic conditions effectively.
12) Maharashtra (Maharastra, Maha-rashtra):
Maharashtra is a state in India where this study on adverse drug reactions was conducted. Understanding the regional health context enables better management and monitoring of drug safety issues in local populations.
13) Ayurveda (Ayus-veda):
Ayurveda is an ancient Indian system of medicine based on holistic principles, emphasizing balance in bodily systems. Its relevance lies in understanding traditional approaches to health that complement modern pharmacological treatments.
14) Kolhapur:
Kolhapur is a city in Maharashtra, India, serving as the locale for the study. It reflects the local population's health profile and the types of medications most commonly used in rural healthcare settings.
15) Village:
A village represents a small community that significantly impacts social and healthcare dynamics. The study examines how medication reactions vary across different demographics, emphasizing the need for localized healthcare solutions.
16) Renuka:
Renuka is a name mentioned in the study's authorship. Individual contributions highlight the importance of collaboration in healthcare research, particularly focusing on adverse drug reactions in specific patient populations.
17) India:
India is a diverse country where different cultural and medicinal practices coexist. It provides a rich context for studying drug interactions and the implications of pharmacovigilance in managing public health challenges.
18) Pur:
Poor refers to individuals experiencing financial hardship, often leading to inadequate access to healthcare. This term highlights the importance of understanding socioeconomic factors influencing health outcomes and medication adherence.
19) Life:
Life encompasses the biological and social experiences that influence health and disease. Understanding the context of life choices helps address lifestyle-associated diseases like hypertension and diabetes through targeted interventions.
20) Surrounding:
Surrounding relates to the immediate environment impacting health decisions. Understanding the social and physical environments of patients aids in improving healthcare accessibility and comprehending the factors influencing adverse drug reactions.
21) Transformation (Transform, Transforming):
Transformed indicates change and progress seen in medical practices. This concept underscores the evolution of pharmacovigilance methodologies and the importance of adapting medical practices to enhance patient care.
22) Discussion:
Discussion is a critical component of research, enabling the analysis and interpretation of findings. It offers insights into the significance of results and implications for clinical practice, particularly concerning ADRs.
23) Developing:
Developing refers to countries or regions experiencing socio-economic progress. The study draws attention to the unique healthcare challenges faced in developing areas, warranting focused pharmacovigilance efforts and drug safety measures.
24) Irritation:
Irritation is a common side effect of certain medications. Understanding the various forms of medication-related irritation helps in assessing drug safety and patient experience, ensuring better therapeutic outcomes.
25) Evolution:
Evolution signifies progression and improvement in scientific understanding and medical practices. The history of drug development reflects evolving methodologies that strive to enhance patient safety and manage adverse drug reactions effectively.
26) Suffering:
Suffering involves the physical and emotional distress experienced by individuals with chronic diseases. Recognizing patient suffering underscores the necessity for effective pharmacovigilance and the development of safer drug options.
27) Swelling:
Swelling, often a side effect of medications like calcium channel blockers, signifies fluid retention. It is crucial to monitor swelling as an adverse drug reaction to enhance patient treatment experiences.
28) Activity:
Activity denotes actions pertinent to health, including physical, social, and medical engagement. Engaging in a healthy lifestyle can mitigate the risks associated with conditions like hypertension and diabetes.
29) Sadhana:
Sadhana appears in the context of authorship, showcasing individual contributions to research. It highlights the collaborative efforts essential for advancing knowledge and practices in healthcare and pharmacovigilance.
30) Babylon:
Babylon refers to an ancient civilization recognized for its contributions to early medicine and healing practices. Studying historical medical systems enriches the understanding of current pharmacological advancements.
31) Greece:
Greece signifies the origin of many foundational concepts in Western medicine, including the Hippocratic Oath. This historical perspective informs modern ethical practices and responsibilities in healthcare.
32) Wisdom:
Wisdom refers to the sound judgment derived from knowledge and experience. It is paramount in healthcare, steering clinicians toward safe and effective treatment regimens while considering the risks of adverse drug reactions.
33) Family:
Family encompasses the social unit considerably influencing health behaviors and outcomes. Understanding the familial contexts of health can guide better psychological support and adherence to medication regimens.
34) Indian:
Indian reflects the cultural and medical practices unique to India, including Ayurveda and herbal remedies. Understanding local healthcare traditions plays a crucial role in enhancing modern pharmacological research and treatment approaches.
35) Sugar:
Sugar is a simple carbohydrate significant concerning diabetes management. Monitoring sugar levels is essential for diabetic patients, as poor management may lead to severe health issues requiring pharmacological intervention.
36) Death:
Death signifies the ultimate consequence of untreated or poorly managed diseases. This underscores the importance of effective drug management and safety measures in preventing complications arising from adverse drug reactions.
37) Cina:
China refers to a geographical location known for its rich traditional medicinal practices, such as Traditional Chinese Medicine. The historical context enriches the understanding of modern medicine's evolution in treating diseases.
38) Egypt:
Egypt is associated with ancient medical knowledge and practices. This historical perspective is vital in understanding the roots of medicine and how past experiences influence contemporary pharmacology and treatment protocols.
39) Beta:
Beta often refers to beta-blockers, a class of medications used to manage hypertension and cardiac conditions. Understanding their role and potential side effects is crucial in pharmacovigilance studies focusing on drug reactions.
Other Science Concepts:
Discover the significance of concepts within the article: ‘Pharmacovigilance: Adverse Drug Reactions in Antihypertensive and Antidiabetic Medications’. Further sources in the context of Science might help you critically compare this page with similair documents:
Public health, Diabetes mellitus, Medical research, Adverse drug reaction, Antidiabetic Drug, Lifestyle disease, Pharmaceutical companies, Hypertension, Kruskal Wallis test, Pharmacovigilance, Patient compliance, Antihypertensive drug, Therapeutic class, Dose response, Non-parametric test, Health professional.